Glycogen Metabolism Flashcards
Epinephrie
Stimulates glycogenolysis
Purpose of glycogen metabolism
Rapid synthesis of glycogen when glucose 6-P is abundant [high blood insulin levels, both liver and muscle]
Rapid degradation of glycogen when glucose 6-P is needed[low insulin/glucagon ratio in liver, muscle contraction in muscle]
phosphoglucomutase
reversibly converts glucose 6 P and glucose 1 P for glycogen degredation and synthesis.
UDP-glucose
highly activated form of glucose which is used for synthesis of glycogen or other glycosylations
Glucose 1-P and UTP are used in an irreversible reaction and UDP-glucose and PPi are formed.
Enzyme: UDP-glucose pyrophosphrylase
Glycogenin
a self-glucosylating enzyme that uses UDP-glucose and adds about 8 glucose units in tandem to its own tyrosine residue.
used in forming a new glygogen unit
After that, glycogen synthaseis able to form alpha-1,4 bonds at the non-reducing ends.
The branching enzyme forms the alpha-1,6 bond
Hormonal regulation of glycogen synthase
Glycogen synthase A is the active form which is not phosphorylated.
High insulin levels activate protein phosphatase1 which cleave the phosphate from glycogen synthase B
Glucagon and epinephrine lead to the formation of the inactive phosphorylated glycogen synthaseB using protein kinaseA
Limit Dextrin
intermediate in glycogen degradation
Branching chains with 4 residues left after initial phosphorylase action.
Substrate for the debranching enzyme
Debranching enzyme
first activity is 4:4 transferase which leads from limit dextrin to longer branches
second activity is 1:6 glucosidase which cleaves the alpha-1,6 bond at the branch point and generates one molecule of free glucose
Branching enzyme
Removes a chain of 6-8 glucosyl residues from the nonreducing end by cleavage of an alpha-1,6 bond and attaches it to a non-terminal glucosyl residue by an alpha 1,6 linkage
Lysosomal acid glucosidase
Needed in lysosomes for glycogen breakdown
Von Gierke Disease
Glycogen storage disease Type 1
Deficiency in Glucose 6 phosphatase
25% of glycogen storage disorders
Characterized by Severe hypoglycemia, hepatomegaly, kidney disease,
Treated with uncooked corn starch or gastric glucose infusion
Pompe Disease
Glycogen storage disease Type 2
Lysosomal glucosidase deficiency
15% of glycogen storage disorders
Characterized by Massive cardiomegaly
Treatable with enzyme infusion
Cori Disease
Glycogen storage disease type 3
Deficiency in debranching enzyme
24% of glycogen storage diseases
Characterized by mild hypoglycemia cardiomyopathy, muscular dystrophy hepatomegaly
Andersen Disease
Glycogen storage disease type 4
Deficiency in branching enzyme
3% of glycogen storage diseases
Characterized by hepatomegaly due to cirrhosis, infintile hypotonia
McArdle Syndrome
Glycogen storage disease type 5
Muscle glycogen phosphorylase deficiency
2% of glycogen storage diseases
characterized by muscle weakness and cramping, no increase of lactic acid in blood after exercise, lack of ATP, normal blood glucose levels